Literature DB >> 1971646

Results of a clinical and pharmacokinetic study of ceftazidime in patients with postoperative pneumonia on assisted ventilation.

M Erttmann1, U Ullmann, E M Koch.   

Abstract

Thirty-three patients who developed nosocomial pneumonia postoperatively were treated with ceftazidime, 4-6 g daily, over an average period of 7 days. Twenty-nine patients were evaluated; 13 (45%) patients were cured, five showed improvement, two relapsed, and one could not be assessed. X-rays of the chest showed no infiltrates in 17 out of the 29 cases (59%) after treatment. On the first day of treatment, ceftazidime concentrations in bronchial secretions of nine patients were estimated. The mean values of serum concentrations were: 15 min after infusion, 98 micrograms ml-1; 60 min, 63; 120 min, 44; 360 min, 20; 480 min, 13 micrograms ml-1. The mean values of the corresponding bronchial secretions were 2.9, 5.8, 10.2, 7.11 and 5.2 micrograms ml-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971646     DOI: 10.1016/0195-6701(90)90080-8

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability.

Authors:  F Bressolle; J E de la Coussaye; R Ayoub; D Fabre; R Gomeni; G Saissi; J J Eledjam; M Galtier
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 2.  Drug treatment of pneumonia in the hospital. What are the choices?

Authors:  M Aoun; J Klastersky
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

3.  Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia.

Authors:  Almos Klekner; Kinga Bagyi; Laszlo Bognar; Attila Gaspar; Melinda Andrasi; Judit Szabo
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.